Literature DB >> 3890536

Gram-negative bacillary infections. Pathogenic and pathophysiologic correlates.

R J Duma.   

Abstract

Gram-negative bacillary infections continue to be extremely important. Escherichia coli is the single most frequently encountered pathogen, followed by organisms belonging to the tribe Klebsiella-Enterobacter-Serratia and Proteus-Providencia. Pseudomonas aeruginosa, although it receives considerable (perhaps excessive) attention, is found relatively less frequently, occurring principally in the hospitalized patient who is immunocompromised. Many factors, both host and microbial, are responsible for invasiveness, virulence, and pathogenicity of gram-negative bacilli, but their relative roles, importance, and the pathophysiologic reactions they trigger are yet to be precisely defined. Certain aspects of many (but certainly not all) of the pathogenic correlates considered important in gram-negative bacillary infections, such as microbial flora, local barriers, surface and serum antibodies, complement, cell-mediated immunity, slime production, capsules, pili, endotoxin, cell wall components, extracellular products, and inoculum size are discussed herein. Points at which preventive or therapeutic strategies might be developed are offered. The benefits of antibiotics in managing susceptible gram-negative bacillary infections appear to be plateauing. If further advances are to be made in the therapy of these infections, new approaches to rapidly identifying the responsible etiologic agent and a better understanding of the factors responsible for invasiveness, virulence, and pathogenicity are needed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890536     DOI: 10.1016/0002-9343(85)90119-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

2.  Characterization of the type 3 fimbrial adhesins of Klebsiella strains.

Authors:  T A Sebghati; T K Korhonen; D B Hornick; S Clegg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

Authors:  H Jin; R Yang; S Marsters; A Ashkenazi; S Bunting; M N Marra; R W Scott; J B Baker
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.

Authors:  Y Lin; W J Leach; W S Ammons
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 5.  Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis.

Authors:  Kevin P Fennelly; Edward C Jones-López
Journal:  Front Immunol       Date:  2015-06-29       Impact factor: 7.561

6.  Importance of the residue 190 on bactericidal activity of the bactericidal/permeability-increasing protein 5.

Authors:  Hanwei Wu; Lu Liu; Muqi Lin; Li Liu; Chen He; Duo Zheng; Weiren Huang
Journal:  Oncotarget       Date:  2016-07-12

7.  Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution.

Authors:  A Hoess; S Watson; G R Siber; R Liddington
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.